Literature DB >> 15530737

Proposal to reclassify Paenibacillus larvae subsp. pulvifaciens DSM 3615 (ATCC 49843) as Paenibacillus larvae subsp. larvae. Results of a comparative biochemical and genetic study.

Jochen Kilwinski1, Martin Peters, Ainura Ashiralieva, Elke Genersch.   

Abstract

The bacterial pathogen Paenibacillus larvae subsp. larvae (P. l. larvae), is the etiological agent of American foulbrood, an extremely contagious and disastrous disease of honeybee brood. In case of American foulbrood the destruction of infected colonies is often considered the only workable control measure. Therefore, the ability to diagnose this disease properly is important to prevent unnecessary economic loss to beekeepers. The development of suitable methods for the early and reliable detection of P. l. larvae is hampered by the fact that the two subspecies of Paenibacillus larvae, P. l. larvae and Paenibacillus larvae subsp. pulvifaciens (P. l. pulvifaciens), seem to be indistinguishable by cultural characteristics as well as by PCR protocols. Here we present an extensive analysis of several P. larvae reference strains. We employed conventional culture techniques, morphological and biochemical identification, PCR-based methods and sequencing of the 16S rDNA. We found indeed that P. l. pulvifaciens strain DSM 3615 is indistinguishable from P. l. larvae (DSM 7030). We did not face any problems to discriminate between P. l. larvae and P. l. pulvifaciens strains DSM 8442 and DSM 8443. Therefore, classification of DSM 3615 as type strain of P. l. pulvifaciens seems not to be justified. We propose to reclassify this strain as P. l. larvae. Former problems in differentiating the two subspecies might have arisen from this misclassification. PCR-based methods as well as appropriate biochemical identification systems provide a reliable means for the discrimination between the two subspecies P. l. larvae and P. l. pulvifaciens.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15530737     DOI: 10.1016/j.vetmic.2004.08.001

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  6 in total

1.  A PCR-Based Method for Distinguishing between Two Common Beehive Bacteria, Paenibacillus larvae and Brevibacillus laterosporus.

Authors:  Jordan A Berg; Bryan D Merrill; Donald P Breakwell; Sandra Hope; Julianne H Grose
Journal:  Appl Environ Microbiol       Date:  2018-10-30       Impact factor: 4.792

2.  Strain- and genotype-specific differences in virulence of Paenibacillus larvae subsp. larvae, a bacterial pathogen causing American foulbrood disease in honeybees.

Authors:  Elke Genersch; Ainura Ashiralieva; Ingemar Fries
Journal:  Appl Environ Microbiol       Date:  2005-11       Impact factor: 4.792

3.  Genetic and biochemical diversity of Paenibacillus larvae isolated from Tunisian infected honey bee broods.

Authors:  Chadlia Hamdi; Jihène Essanaa; Luigi Sansonno; Elena Crotti; Khaoula Abdi; Naima Barbouche; Annalisa Balloi; Elena Gonella; Alberto Alma; Daniele Daffonchio; Abdellatif Boudabous; Ameur Cherif
Journal:  Biomed Res Int       Date:  2013-09-02       Impact factor: 3.411

4.  Production of the catechol type siderophore bacillibactin by the honey bee pathogen Paenibacillus larvae.

Authors:  Gillian Hertlein; Sebastian Müller; Eva Garcia-Gonzalez; Lena Poppinga; Roderich D Süssmuth; Elke Genersch
Journal:  PLoS One       Date:  2014-09-19       Impact factor: 3.240

5.  Biological effects of paenilamicin, a secondary metabolite antibiotic produced by the honey bee pathogenic bacterium Paenibacillus larvae.

Authors:  Eva Garcia-Gonzalez; Sebastian Müller; Gillian Hertlein; Nina Heid; Roderich D Süssmuth; Elke Genersch
Journal:  Microbiologyopen       Date:  2014-07-16       Impact factor: 3.139

6.  Multilocus sequence typing, biochemical and antibiotic resistance characterizations reveal diversity of North American strains of the honey bee pathogen Paenibacillus larvae.

Authors:  Sasiprapa Krongdang; Jay D Evans; Jeffery S Pettis; Panuwan Chantawannakul
Journal:  PLoS One       Date:  2017-05-03       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.